Showing results (221-230 of 277) with videos related to

Sort By:
Pageof 28
Blood|November 11, 2006
Circulating proteasome levels are an independent prognostic factor for survival in multiple myelomaChristian Jakob, Karl Egerer, Peter Liebisch, et al.
Leukemia & Lymphoma|June 11, 2014
A gene expression based predictor for high risk myeloma treated with intensive therapy and autologous stem cell rescuePing Wu, Brian A Walker, Annemiek Broyl, et al.
Leukemia|June 22, 2018
Characterisation of immunoparesis in newly diagnosed myeloma and its impact on progression-free and overall survival in both old and recent myeloma trialsJennifer L J Heaney, John P Campbell, Gulnaz Iqbal, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 8, 2021
Impact of Etiological Cytogenetic Abnormalities on the Depth of Immunoparesis and Survival in Newly Diagnosed Multiple MyelomaJessica Caro, David Cairns, Tom Menzies, et al.
British Journal of Haematology|May 31, 2013
Improved risk stratification in myeloma using a microRNA-based classifierPing Wu, Luca Agnelli, Brian A Walker, et al.
Blood Advances|July 5, 2022
Clinical characteristics and outcomes of IgD myeloma: experience across UK national trialsCharles Agbuduwe, Gulnaz Iqbal, David Cairns, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 29, 2025
Evaluating the Real-World Value of Daratumumab Addition to Multiple Myeloma Induction Therapy by Real-World Minimal Residual Disease Assessment and Extended Genetic ProfilingGiuseppe Bertuglia, Elisa Seneca, Timothy Corbett, et al.
Blood Advances|May 21, 2020
Search for multiple myeloma risk factors using Mendelian randomizationMolly Went, Alex J Cornish, Philip J Law, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|December 6, 2008
The synthesis and one- and two-photon optical properties of dipolar, quadrupolar and octupolar donor-acceptor molecules containing dimesitylboryl groupsJonathan C Collings, Suk-Yue Poon, Céline Le Droumaguet, et al.
The Lancet. Haematology|November 18, 2017
Response comparison of multiple myeloma and monoclonal gammopathy of undetermined significance to the same anti-myeloma therapy: a retrospective cohort studyJohn P Campbell, Jennifer L J Heaney, Sankalp Pandya, et al.
Pageof 28